Is Tenet Healthcare (THC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research • 18 hours ago

Tenet Healthcare Corporation (THC) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Tenet Healthcare Corporation (THC) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seeking Alpha • May 14, 2026

Why Tenet Healthcare (THC) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • May 8, 2026

THC Beats Q1 Earnings Estimates on Strong Ambulatory Growth, Ups '26 EPS View

Tenet Healthcare tops Q1 EPS estimates as admissions and ambulatory growth drive gains, but payer mix pressures and rising costs weigh on margins.

Zacks Investment Research • May 6, 2026

Here is What to Know Beyond Why Tenet Healthcare Corporation (THC) is a Trending Stock

Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks Investment Research • May 6, 2026

Tenet to Participate in the BofA Securities Health Care Conference

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the BofA Securities Health Care Conference on Wednesday, May 13, 2026.

Business Wire • May 6, 2026

Tenet (THC) is an Incredible Growth Stock: 3 Reasons Why

Tenet (THC) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks Investment Research • May 5, 2026

Why Tenet Healthcare (THC) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • May 4, 2026

Brokers Suggest Investing in Tenet (THC): Read This Before Placing a Bet

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Zacks Investment Research • May 1, 2026

Tenet Healthcare: I Am Caring A Lot More At Current Levels

Tenet Healthcare trades at just 10x adjusted earnings after a 30% pullback from recent highs, making valuation compelling. 2025 adjusted earnings reached $17 per share, exceeding prior guidance, while the 2026 outlook suggests continued earnings stability and robust buybacks. Revenue growth is driven by higher pricing, with flat volumes and margin pressure, yet overall business stability is maintained.

Seeking Alpha • May 1, 2026